Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
33 studies found for:    Open Studies | "Refractive Errors"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Refractive Errors"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Condition: Refractive Error
Intervention:
2 Unknown  Piggyback Sulcoflex Toric IOL for Correcting Refractive Error Following Corneal Transplantation
Conditions: Refractive Error;   Corneal Implantation;   Intraocular Lens Implantation
Interventions: Procedure: toric intraocular lens implantation;   Procedure: Sulcoflex intraocular lens implantation
3 Recruiting Dispensing Study to Assess Visual Performance of Prototype Contact Lenses
Conditions: Presbyopia;   Refractive Error
Intervention: Device: Etafilcon A, Lotrafilcon B , Senofilcon A
4 Recruiting Optical Defocus to Stimulate Eye Elongation in Hyperopia
Conditions: Hyperopia;   Refractive Error
Interventions: Device: Simultaneous Vision Bifocal Soft Contact Lenses;   Device: Single Vision Soft Contact Lenses
5 Recruiting Bifocal Lenses In Nearsighted Kids
Condition: Refractive Errors
Interventions: Device: Biofinity Multifocal D +1.50 add;   Device: Biofinity Multifocal D +2.50 add;   Device: Biofinity
6 Unknown  Safety and Efficacy Study to Evaluate the Treatment of Both Near and Distance Vision in a Simultaneous Laser Procedure
Conditions: Myopia;   Hyperopia;   Presbyopia;   Refractive Error
Intervention: Procedure: Supracor
7 Recruiting FID# 114657 in Contact Lens Wearers
Conditions: Refractive Error;   Symptoms of Ocular Dryness
Interventions: Drug: FID# 114657 eye drops (10 ml);   Drug: Saline eye drops (15 ml);   Device: Habitual contact lenses
8 Recruiting Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric
Condition: Refractive Error
Interventions: Device: Nelfilcon A multifocal contact lenses;   Device: Nelfilcon A toric contact lenses;   Device: Nelfilcon A sphere contact lenses
9 Recruiting Comparison of Intraocular Lens Power Calculation Methods After Corneal Laser Refractive Surgery in Axial and Refractive Ammertropia
Conditions: Cataract;   Refractive Errors
Intervention:
10 Unknown  The Effect of Gabapentin (Neurentin) and Pregabalin (Lyrica) in Pain Reduction After Photorefractive Keratectomy
Condition: Refractive Errors
Intervention: Drug: Pregabalin
11 Recruiting A New More Efficient Cycloplegia Scheme
Condition: Refractive Errors
Interventions: Drug: Cyclopentolate;   Drug: Cyclopentolate+tropicamide+phenylephrine
12 Not yet recruiting Myopia:the Role of Cone Opsin Mutations & Glasses That Control Axial Elongation
Condition: Myopia
Interventions: Other: Spectacles with red-blocking tint;   Other: Spectacles with holographic diffuser and color neutral tint;   Other: Spectacles with holographic diffuser and red-blocking tint;   Other: Spectacles with color neutral tint
13 Recruiting The Efficacy and Safety of Periocular Acupoint Stimulation on Myopia Progression in Children
Condition: Myopia
Intervention: Device: massager
14 Unknown  The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
Condition: Myopia
Intervention:
15 Recruiting Limbal Relaxing Incision Versus Toric Intraocular Lens for Corneal Astigmatism During Cataract Surgery.
Conditions: Astigmatism;   Cataract
Interventions: Procedure: Limbal Relaxing Incisions;   Device: Toric Intraocular Lens
16 Unknown  Early Vitrectomy for Macular Tractional Maculopathy
Condition: Myopia, Degenerative
Intervention: Procedure: Early vitrectomy
17 Recruiting Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Condition: Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Interventions: Drug: Ranibizumab 0.5mg;   Drug: Rranibizumab 0.5 mg;   Drug: Verteporfin PDT
18 Recruiting A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
Condition: Choroidal Neovascularization Secondary to Pathologic Myopia
Intervention: Drug: Ranibizumab
19 Unknown  Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System
Condition: Hyperopia
Intervention: Device: Optimal Keratoplasty
20 Unknown  Genomewide Screening of Pathological Myopia
Condition: Pathological Myopia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years